Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference28 articles.
1. Potent potassium-competitive acid blockers: a new era for the treatment of acid-related diseases;Oshima;J Neurogastroenterol Motil,2018
2. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion;Dammann;Eur J Gastroenterol Hepatol,1999
3. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases;Andersson;Pharmacol Ther,2005
4. Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment;Bytzer;Scand J Gastroenterol,2006
5. Tegoprazan, a novel potassium-competitive acid blocker to control gastric acid secretion and motility;Takahashi;J Pharmacol Exp Ther,2018
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15
2. Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial;Clinical Drug Investigation;2024-04-13
3. History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs;The Korean Journal of Helicobacter and Upper Gastrointestinal Research;2023-09-15
4. Evaluation of the comparative pharmacokinetic properties of a new orally disintegrating tablet of tegoprazan in healthy Korean subjects;Int. Journal of Clinical Pharmacology and Therapeutics;2023-09-01
5. Prediction of the Drug–Drug Interaction Potential between Tegoprazan and Amoxicillin/Clarithromycin Using the Physiologically Based Pharmacokinetic and Pharmacodynamic Model;Pharmaceuticals;2023-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3